STK11 and breast carcinoma: Our study uncovers that BITC concertedly modulates tumor-suppressors- p53, p73 and LKB1 and not only activates p53-signaling networks in p53-wild-type breast cancer but also functionally restores p53-signaling in p53-mutant breast cancer.